TLM Utility Nav

Clinical Management of Immune-Mediated Liver Diseases

Description

Presenters review the management of autoimmune-mediated liver diseases including autoimmune hepatititis, primary biliary cholangitis, primary sclerosing cholangitis, and immune-mediated DILI. The program also includes a panel discussion of a complex clinical case followed by a question-and-answer period. 

Journey Maps

Objectives

  • Review the pathophysiology of immune-mediated liver diseases.
  • Describe appropriate diagnostic testing and criteria in the diagnosis of immune-mediated liver diseases.
  • Identify treatment indications and appropriate pharmacologic therapies for the management of immune-mediated liver diseases.
Chair

Dawn Drazek, MSN, CRNP, AGPCNP-BC

Carolinas Medical Center